Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP697297.RAdWguExL1mDnG88vsLimobkaSmFq1q0sH0AwrhOlDu64130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP697297.RAdWguExL1mDnG88vsLimobkaSmFq1q0sH0AwrhOlDu64130_assertion type Assertion NP697297.RAdWguExL1mDnG88vsLimobkaSmFq1q0sH0AwrhOlDu64130_head.
- NP697297.RAdWguExL1mDnG88vsLimobkaSmFq1q0sH0AwrhOlDu64130_assertion description "[Finally, treatment of THM mice with an ACE inhibitor, enalapril, improved osteoporosis and hypertension, whereas treatment with losartan, an angiotensin receptor blockers specific for AT1, resulted in exacerbation of the low bone mass phenotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP697297.RAdWguExL1mDnG88vsLimobkaSmFq1q0sH0AwrhOlDu64130_provenance.
- NP697297.RAdWguExL1mDnG88vsLimobkaSmFq1q0sH0AwrhOlDu64130_assertion evidence source_evidence_literature NP697297.RAdWguExL1mDnG88vsLimobkaSmFq1q0sH0AwrhOlDu64130_provenance.
- NP697297.RAdWguExL1mDnG88vsLimobkaSmFq1q0sH0AwrhOlDu64130_assertion SIO_000772 18847324 NP697297.RAdWguExL1mDnG88vsLimobkaSmFq1q0sH0AwrhOlDu64130_provenance.
- NP697297.RAdWguExL1mDnG88vsLimobkaSmFq1q0sH0AwrhOlDu64130_assertion wasDerivedFrom befree-2016 NP697297.RAdWguExL1mDnG88vsLimobkaSmFq1q0sH0AwrhOlDu64130_provenance.
- NP697297.RAdWguExL1mDnG88vsLimobkaSmFq1q0sH0AwrhOlDu64130_assertion wasGeneratedBy ECO_0000203 NP697297.RAdWguExL1mDnG88vsLimobkaSmFq1q0sH0AwrhOlDu64130_provenance.